ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALXO ALX Oncology Holdings

未开盘 12-18 16:00:00 EST

1.84

+0.05

+2.79%

盘后1.84

+0.000.00%

18:25 EST

最高2.05	最低1.68	成交量320.88万
今开1.82	昨收1.79	日振幅20.67%
总市值9,705万	流通市值6,463万	总股本5,274万
成交额611.22万	换手率9.13%	流通股本3,513万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALXO","market":"US","secType":"STK","nameCN":"ALX Oncology Holdings","latestPrice":1.84,"timestamp":1734555600000,"preClose":1.79,"halted":0,"volume":3208807,"hourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.84,"latestTime":"18:25 EST","volume":9487,"amount":17481.43,"timestamp":1734564329422},"delay":0,"floatShares":35126938,"shares":52743104,"eps":-2.968332,"marketStatus":"未开盘","marketStatusCode":0,"change":0.05,"latestTime":"12-18 16:00:00 EST","open":1.82,"high":2.05,"low":1.68,"amount":6112166.378147201,"amplitude":0.206704,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.968332,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734598800000},"adr":0,"listingDate":1594958400000,"adjPreClose":1.79,"preHourTrading":{"tag":"盘前","latestPrice":1.82,"preClose":1.79,"latestTime":"09:29 EST","volume":16356,"amount":30429.56109,"timestamp":1734532141023},"postHourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.84,"latestTime":"18:25 EST","volume":9487,"amount":17481.43,"timestamp":1734564329422},"volumeRatio":2.2985838752723886,"impliedVol":0.7267,"impliedVolPercentile":0.2151},"requestUrl":"/m/hq/s/ALXO","defaultTab":"news","newsList":[{"id":"2492848841","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492848841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492848841?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:32","pubTimestamp":1734532352,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时32分，Alx Oncology Holdings Inc.股票出现波动，股价急速下跌6.15%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822323395ea548a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822323395ea548a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4007","ALXO","BK4139"],"gpt_icon":0},{"id":"2492965312","title":"Alx Oncology Holdings Inc.盘中异动 早盘大幅拉升6.49%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492965312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492965312?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:37","pubTimestamp":1734446264,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时37分，Alx Oncology Holdings Inc.股票出现波动，股价快速上涨6.49%。截至发稿，该股报1.64美元/股，成交量2.9911万股，换手率0.06%，振幅7.14%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223744ab7f54d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223744ab7f54d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2490197338","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.30%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490197338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490197338?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:17","pubTimestamp":1734016649,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时17分，Alx Oncology Holdings Inc.股票出现异动，股价大幅上涨5.30%。截至发稿，该股报1.59美元/股，成交量33.4909万股，换手率0.63%，振幅6.20%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212231729ab72bf43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212231729ab72bf43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2490011535","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌5.59%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490011535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490011535?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:34","pubTimestamp":1733841272,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时34分，Alx Oncology Holdings Inc.股票出现异动，股价快速下跌5.59%。截至发稿，该股报1.62美元/股，成交量18.0682万股，换手率0.34%，振幅4.53%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022343295e8ae4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022343295e8ae4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2490217773","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490217773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490217773?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:34","pubTimestamp":1733754863,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时34分，Alx Oncology Holdings Inc.股票出现异动，股价快速拉升5.56%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223423ab6a0b45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223423ab6a0b45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2489231648","title":"Alx Oncology Holdings Inc.盘中异动 快速跳水5.25%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489231648?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:00","pubTimestamp":1733497248,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时00分，Alx Oncology Holdings Inc.股票出现异动，股价快速跳水5.25%。截至发稿，该股报1.72美元/股，成交量18.1857万股，换手率0.34%，振幅5.52%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623004898e5e31a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623004898e5e31a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2489114305","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.10%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489114305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489114305?lang=zh_cn&edition=full","pubTime":"2024-12-05 00:43","pubTimestamp":1733330582,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日00时43分，Alx Oncology Holdings Inc.股票出现波动，股价快速上涨5.10%。截至发稿，该股报1.63美元/股，成交量34.5714万股，换手率0.66%，振幅7.09%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205004302971ba6b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205004302971ba6b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2488670187","title":"Alx Oncology Holdings Inc.盘中异动 早盘急速上涨5.07%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488670187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488670187?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:16","pubTimestamp":1733152576,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时16分，Alx Oncology Holdings Inc.股票出现异动，股价快速拉升5.07%。截至发稿，该股报1.56美元/股，成交量17.2314万股，换手率0.33%，振幅5.41%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202231616971b2fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202231616971b2fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2486794002","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.44%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486794002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486794002?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:17","pubTimestamp":1732634275,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时17分，Alx Oncology Holdings Inc.股票出现波动，股价大幅拉升5.44%。截至发稿，该股报1.55美元/股，成交量12.0949万股，换手率0.23%，振幅4.76%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126231755abe0d361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126231755abe0d361&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2486080404","title":"Alx Oncology Holdings Inc.盘中异动 早盘快速上涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486080404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486080404?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:35","pubTimestamp":1732545348,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时35分，Alx Oncology Holdings Inc.股票出现波动，股价快速上涨5.67%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223548971a85d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223548971a85d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2485298913","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298913?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291309,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时01分，Alx Oncology Holdings Inc.股票出现波动，股价快速拉升5.81%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300014998e44317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300014998e44317&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2485443568","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485443568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485443568?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:55","pubTimestamp":1732211747,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时55分，Alx Oncology Holdings Inc.股票出现异动，股价快速拉升5.37%。截至发稿，该股报1.28美元/股，成交量23.4374万股，换手率0.44%，振幅4.96%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112201554798e43fbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112201554798e43fbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2485198014","title":"Alx Oncology Holdings Inc.2024财年第三财季实现净利润-30.71百万美元，同比增加39.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485198014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485198014?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:00","pubTimestamp":1732204825,"startTime":"0","endTime":"0","summary":"11月22日，Alx Oncology Holdings Inc.公布财报，公告显示公司2024财年第三财季净利润为-30.71百万美元，同比增加39.77%；其中营业收入为0.00美元，每股基本收益为-0.58美元。从资产负债表来看，Alx Oncology Holdings Inc.总负债48.91百万美元，其中短期债务1.87百万美元，资产负债比为0.04，流动比率为0.05。机构评级：截至2024年11月22日，当前有5家机构对Alx Oncology Holdings Inc.目标价做出预测，其中目标均价为10.40美元，其中最低目标价为3.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122000034abd50d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122000034abd50d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO"],"gpt_icon":0},{"id":"2484860909","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌5.43%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484860909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484860909?lang=zh_cn&edition=full","pubTime":"2024-11-19 04:53","pubTimestamp":1731963194,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日04时53分，Alx Oncology Holdings Inc.股票出现异动，股价快速下跌5.43%。截至发稿，该股报1.22美元/股，成交量161.476万股，换手率3.06%，振幅5.43%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119045315971a744f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119045315971a744f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2483372414","title":"Alx Oncology Holdings Inc.盘中异动 快速下挫6.02%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372414?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:32","pubTimestamp":1731681134,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时32分，Alx Oncology Holdings Inc.股票出现波动，股价大幅跳水6.02%。截至发稿，该股报1.25美元/股，成交量5.2196万股，换手率0.10%，振幅4.51%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为1.15%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223214a23b5c55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223214a23b5c55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2483088263","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483088263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483088263?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:44","pubTimestamp":1731509068,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时44分，Alx Oncology Holdings Inc.股票出现波动，股价大幅上涨5.22%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224428971a64c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224428971a64c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2482388617","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.52%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482388617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482388617?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335499,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分，Alx Oncology Holdings Inc.股票出现异动，股价急速拉升5.52%。截至发稿，该股报1.53美元/股，成交量8839股，换手率0.02%，振幅0.00%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223139971a5ad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223139971a5ad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2481879483","title":"ALX Oncology Holdings Inc    预计每股亏损 72 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481879483","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481879483?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:47","pubTimestamp":1731080822,"startTime":"0","endTime":"0","summary":"   * ALX Oncology Holdings Inc    预计在公布截至2024年12月31日的财报时，季度收入将保持不变。*    * LSEG的分析师平均预计ALX Oncology Holdings Inc每股亏损72美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 5 个 \"强烈买入 \"或 \"买入\"，2 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 ALX Oncology Holdings Inc 的 12 个月目标价中位数为 6.00 美元，高于其最新收盘价 1.51 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX","ALXO"],"gpt_icon":0},{"id":"2481102602","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.63%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102602?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:45","pubTimestamp":1731077155,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时45分，Alx Oncology Holdings Inc.股票出现波动，股价大幅拉升5.63%。截至发稿，该股报1.60美元/股，成交量5.1902万股，换手率0.10%，振幅4.21%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224555a224cbfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224555a224cbfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2481986065","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481986065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481986065?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:54","pubTimestamp":1730904841,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时54分，Alx Oncology Holdings Inc.股票出现波动，股价急速下挫5.26%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106225401971a4cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106225401971a4cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alxoncology.com","stockEarnings":[{"period":"1week","weight":0.2185},{"period":"1month","weight":0.5082},{"period":"3month","weight":-0.1521},{"period":"6month","weight":-0.7195},{"period":"1year","weight":-0.8685},{"period":"ytd","weight":-0.8764}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ALX Oncology Holdings Inc.于2020年4月1日成立。该公司是一家临床阶段免疫肿瘤学公司，致力于通过开发阻断CD47检查点通路并连接先天性和适应性免疫系统的疗法，帮助患者抗癌。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.135783},{"month":2,"riseRate":0.75,"avgChangeRate":-0.031126},{"month":3,"riseRate":0,"avgChangeRate":-0.176518},{"month":4,"riseRate":0.5,"avgChangeRate":0.111643},{"month":5,"riseRate":0.25,"avgChangeRate":-0.187435},{"month":6,"riseRate":0.5,"avgChangeRate":-0.07132},{"month":7,"riseRate":0.5,"avgChangeRate":-0.030725},{"month":8,"riseRate":0.6,"avgChangeRate":-0.008884},{"month":9,"riseRate":0.4,"avgChangeRate":-0.072845},{"month":10,"riseRate":0.6,"avgChangeRate":0.071979},{"month":11,"riseRate":0.6,"avgChangeRate":0.111833},{"month":12,"riseRate":0.8,"avgChangeRate":0.189303}],"exchange":"NASDAQ","name":"ALX Oncology Holdings","nameEN":"ALX Oncology Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ALX Oncology Holdings,ALXO,ALX Oncology Holdings股票,ALX Oncology Holdings股票老虎,ALX Oncology Holdings股票老虎国际,ALX Oncology Holdings行情,ALX Oncology Holdings股票行情,ALX Oncology Holdings股价,ALX Oncology Holdings股市,ALX Oncology Holdings股票价格,ALX Oncology Holdings股票交易,ALX Oncology Holdings股票购买,ALX Oncology Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}